CGEM insider transactions

Chief Scientific Officer Michaelson Jennifer exercised 4,000 shares at a strike of $4.30 and sold $116,996 worth of shares (8,000 units at $14.62) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 166,844 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $125,440 worth of shares (8,000 units at $15.68) and exercised 4,000 shares at a strike of $4.30, decreasing direct ownership by 2% to 170,844 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $25,169 worth of shares (1,780 units at $14.14), decreasing direct ownership by 1% to 174,844 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $76,617 worth of shares (5,353 units at $14.31), decreasing direct ownership by 3% to 176,624 units (SEC Form 4)

Chief Legal Officer Sumer Jacquelyn L sold $52,106 worth of shares (3,601 units at $14.47), decreasing direct ownership by 3% to 128,089 units (SEC Form 4)

Chief Medical Officer Jones Jeffrey Alan sold $66,302 worth of shares (4,582 units at $14.47), decreasing direct ownership by 3% to 159,968 units (SEC Form 4)

President and CEO Ahmed Nadim sold $195,562 worth of shares (13,515 units at $14.47), decreasing direct ownership by 3% to 390,803 units (SEC Form 4)

Chief Medical Officer Jones Jeffrey Alan sold $67,855 worth of shares (4,982 units at $13.62), decreasing direct ownership by 3% to 164,550 units (SEC Form 4)

Chief Financial Officer Fenton Mary Kay sold $59,901 worth of shares (4,398 units at $13.62), decreasing direct ownership by 3% to 126,380 units (SEC Form 4)

President and CEO Ahmed Nadim sold $223,109 worth of shares (16,381 units at $13.62), decreasing direct ownership by 4% to 404,318 units (SEC Form 4)

Chief Legal Officer Sumer Jacquelyn L sold $50,966 worth of shares (3,742 units at $13.62), decreasing direct ownership by 3% to 131,690 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $165,366 worth of shares (11,742 units at $14.08) and exercised 8,000 shares at a strike of $4.30, decreasing direct ownership by 2% to 181,977 units (SEC Form 4)

SEC Form 4 filed by Chief Medical Officer Jones Jeffrey Alan

Chief Financial Officer Fenton Mary Kay was granted 68,750 shares, increasing direct ownership by 111% to 130,778 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer was granted 57,500 shares, increasing direct ownership by 45% to 185,719 units (SEC Form 4)

SEC Form 4 filed by President and CEO Ahmed Nadim

SEC Form 4 filed by Chief Legal Officer Sumer Jacquelyn L

SEC Form 4 filed by Chief Business Officer Savill Corrine

Chief Scientific Officer Michaelson Jennifer sold $5,004 worth of shares (416 units at $12.03), decreasing direct ownership by 0.32% to 128,219 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $49,200 worth of shares (4,000 units at $12.30), decreasing direct ownership by 3% to 128,635 units (SEC Form 4)

Chief Financial Officer Fenton Mary Kay was granted 27 shares, increasing direct ownership by 0.04% to 62,028 units (SEC Form 4)

President and CEO Ahmed Nadim sold $99,319 worth of shares (9,922 units at $10.01), decreasing direct ownership by 2% to 420,699 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $13,463 worth of shares (1,345 units at $10.01), decreasing direct ownership by 1% to 132,635 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $28,024 worth of shares (2,898 units at $9.67), decreasing direct ownership by 2% to 133,980 units (SEC Form 4)

Chief Legal Officer Sumer Jacquelyn L sold $33,652 worth of shares (3,480 units at $9.67), decreasing direct ownership by 3% to 135,432 units (SEC Form 4)

Chief Medical Officer Jones Jeffrey Alan sold $44,791 worth of shares (4,632 units at $9.67), decreasing direct ownership by 3% to 169,532 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $38,433 worth of shares (3,143 units at $12.23), decreasing direct ownership by 2% to 136,878 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $49,200 worth of shares (4,000 units at $12.30), decreasing direct ownership by 3% to 138,004 units (SEC Form 4)

Large owner Lynx1 Capital Management Lp bought $1,391,686 worth of shares (165,667 units at $8.40) (SEC Form 4)

Large owner Lynx1 Capital Management Lp bought $114,048 worth of shares (15,032 units at $7.59) and bought $1,989,864 worth of shares (233,717 units at $8.51) (SEC Form 4)

Large owner Lynx1 Capital Management Lp bought $3,593,698 worth of shares (556,300 units at $6.46) and bought $6,233,243 worth of shares (903,341 units at $6.90) (SEC Form 4)

New insider Lynx1 Capital Management Lp claimed ownership of 7,089,443 shares (SEC Form 3)

SEC Form 4 filed by Director Doyle Mittie

SEC Form 3 filed by new insider Allen Andrew R

SEC Form 3 filed by new insider Doyle Mittie

SEC Form 4 filed by Director Allen Andrew R

SEC Form 4 filed by Director Ryan David P.

SEC Form 4 filed by Director Rosenberg Anthony

SEC Form 4 filed by Director Webster Stephen W

SEC Form 4 filed by Director Meek David D.

SEC Form 4 filed by Director Martin Anne-Marie

President and CEO Ahmed Nadim sold $106,872 worth of shares (12,529 units at $8.53), decreasing direct ownership by 3% to 430,621 units (SEC Form 4)

Chief Medical Officer Jones Jeffrey Alan sold $41,754 worth of shares (4,895 units at $8.53), decreasing direct ownership by 3% to 174,164 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $32,039 worth of shares (3,756 units at $8.53), decreasing direct ownership by 3% to 142,004 units (SEC Form 4)

Chief Legal Officer Sumer Jacquelyn L sold $32,039 worth of shares (3,756 units at $8.53), decreasing direct ownership by 3% to 136,895 units (SEC Form 4)

Chief Business Officer Savill Corrine was granted 37,500 shares, increasing direct ownership by 18% to 240,990 units (SEC Form 4)

Chief Legal Officer Sumer Jacquelyn L was granted 50,000 shares, increasing direct ownership by 55% to 140,651 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer was granted 50,000 shares, increasing direct ownership by 52% to 145,760 units (SEC Form 4)

Chief Medical Officer Jones Jeffrey Alan was granted 65,000 shares, increasing direct ownership by 57% to 179,059 units (SEC Form 4)

Chief Financial Officer Fenton Mary Kay was granted 60,000 shares (SEC Form 4)

President and CEO Ahmed Nadim was granted 180,000 shares, increasing direct ownership by 68% to 443,150 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $50,040 worth of shares (4,000 units at $12.51), decreasing direct ownership by 4% to 95,760 units (SEC Form 4)

President and CEO Ahmed Nadim sold $99,708 worth of shares (8,400 units at $11.87), decreasing direct ownership by 3% to 263,150 units (SEC Form 4)

Chief Medical Officer Jones Jeffrey Alan sold $52,851 worth of shares (4,632 units at $11.41), decreasing direct ownership by 4% to 114,059 units (SEC Form 4)

Chief Legal Officer Sumer Jacquelyn L sold $39,730 worth of shares (3,482 units at $11.41), decreasing direct ownership by 4% to 90,651 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $53,547 worth of shares (4,693 units at $11.41), decreasing direct ownership by 4% to 99,760 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $43,682 worth of shares (3,489 units at $12.52), decreasing direct ownership by 3% to 104,453 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $125,120 worth of shares (8,000 units at $15.64), decreasing direct ownership by 7% to 107,942 units (SEC Form 4)

Chief Scientific Officer Michaelson Jennifer sold $144,720 worth of shares (8,000 units at $18.09), decreasing direct ownership by 6% to 115,942 units (SEC Form 4)

SEC Form 3 filed by new insider Thistle Mary